1.75
-0.01(-0.57%)
Currency In USD
Address
360 Massachusetts Avenue
Acton, MA 01720
United States of America
Phone
844 327 7078
Website
Sector
Healthcare
Industry
Medical - Devices
Employees
7
First IPO Date
November 10, 2021
| Name | Title | Pay | Year Born |
| Mr. Indranil Dey | Principal Financial, Accounting & Executive Officer, President, Chief Executive Officer and Director | 290,887 | 1964 |
| Dr. Jason Cook | Chief Technology Officer | 251,068 | 1983 |
| Dr. Mark W. Feinberg M.D. | Chief Medical Advisor | 0 | N/A |
| Mr. Mark W. Feinberg M.D., Ph.D. | Chief Medical Advisor | 0 | N/A |
| Mr. Kevin Vance | Chief Commercial Officer | 0 | 1958 |
| Mr. Les DeLuca | Vice President of Operations | 0 | N/A |
Bluejay Diagnostics, Inc., a diagnostic company, develops and markets patient products for triage, diagnosis, and monitoring of disease progression in the United States. It is developing Symphony platform, a technology platform comprising Symphony Fluorescence Immuno-analyzer that orchestrates blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge Library, which includes reagents and components. The company also offers ALLEREYE diagnostic test, a POC device for the diagnosis of allergic conjunctivitis. In addition, it develops biomarkers for detection of other diseases such as hsTNT/I for myocardial injury and NT-proBNP for cardiac heart failure. It has a license and supply agreement with Toray Industries, Inc. for making and distributing the protein detection chips. Bluejay Diagnostics, Inc. was incorporated in 2015 and is headquartered in Acton, Massachusetts.